APPLICATIONS PUBLISHED 28 APRIL 2004

Published: 1-Oct-2004

The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492


The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492

  • Aqueous nacreous concentrate compsns comprising ethoxylated glycerides
    Kao Corp 1411892*

  • Flat, oral dosage form comprising particles containing active ingredients
    LTS Lohmann Therapie-Systeme 1411893*

  • Pharmaceutical preparations containing ion exchange resins charged with active ingredients
    Bayer HealthCare 1411894*

  • Oral pharmaceutical compsn comprising an active principle capable of being subjected to a high effect during its first passage through the intestine
    Gattefrost Holding 1411895*

  • Surfactant compounds and uses thereof
    Glaxo Group 1411896*

  • Compsns and methods for intracellular delivery
    Yissum Research Development Company of the Hebrew University of Jerusalem 1411897*

  • Pharmaceutical compsn comprising lipids with a polar and a nonpolar moiety
    Mitsubishi Chemical 1411898*

  • Taste masking compsn
    Bristol-Myers Squibb; Corbo, Michael; Migton, John; Patell, Mahesh 1411899*

  • Pharmaceutical compsns for the coordinated delivery of NSAIDs
    Pozen 1411900*

  • Gastric retention controlled drug delivery system
    Sun Pharmaceuticals Industries 1411901*

  • Two part hard shell capsule made of poly (1,4-alpha-D-glucan) and starch
    Celanese Ventures 1411902*

  • Biodegradable polyhydric alcohol esters
    Cornell Research Foundation 1411903*

  • Sustained release pharmaceutical compsn
    Smart Drug System 1411904*

  • Sustained release delivery system
    Smart Drug System 1411905*

  • TTS with peel-off film with reduced resistance to tearing
    Hexal 1411906*

  • Inhibitors of HB-EGF (ERBB) receptors for treating myeloma
    Centre Hospitalier Universitaire de Montpellier 1411907*

  • Treatment of nail infections with NO
    Aberdeen University 1411908*

  • Pharmaceutical compsn comprising (-)-secoisolariceresinol
    Council of Scientific and Industrial Research 1411909*

  • (+)-cycloolivil as antioxidant obtained from stereospermum personatum
    Council of Scientific and Industrial Research 1411910*

  • Beta-adernergic blockade reversal of catabolism after severe burn
    Research Development Foundation 1411911*

  • Treatment of chronic pain with 3-aryloxy-3-phenylpropanamines
    Pharmacia & Upjohn 1411912*

  • Antimicrobial nanoemulsion compsn and methods
    The Regents of the University of Michigan 1411913*

  • Use of a PDE4 inhibitor in combination with an anticholinergic agent for the treatment of pulmonary disease such as asthma
    Glaxo Group 1411914*

  • Nitrate ester cyclodextrin complexes for treating diseases, particularly coronary diseases
    Dynamit Nobel 1411915*

  • Methods and materials for the treatment of testosterone deficiency in men
    Zonagen 1411916*

  • Carbamate compounds for use in preventing or treating movement disorders
    Ortho-McNeil Pharmaceuticals 1411917*

  • Methods to mobilise progenitor/stem cells
    Anormed 1411918*

  • (-)-olivil as antioxidant
    Council of Scientific and Industrial Research 1411919*

  • You may also like